









Markets
/
Stocks
/
nasdaq-tkno
/

Alpha Teknova Inc

TKNO

4.640USD

+0.240+5.45%

Close 09/18, 16:00（ET）Quotes delayed by 15 min

248.31MMarket Cap

LossP/E TTM



Alpha Teknova Inc

4.640

+0.240+5.45%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated：2025-09-17

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

66 / 207

Overall Ranking

197 / 4723

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 6 analysts

Buy

Current Rating

10.000

Target Price

+121.24%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

Alpha Teknova, Inc. is a producer of critical reagents for the research, discovery, development, and commercialization of therapies, vaccines, and molecular diagnostics. It offers two primary business lines, which include lab essentials and clinical solutions. It also offers three primary product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. The Company offers its liquid cell culture media and supplements and molecular biology reagents in both of its two product categories; pre-poured media plates are available in its Lab Essentials category only. Its customers include pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostics franchises, and academic and government research institutions developing vaccines and therapies and performing basic research.

Growing

The company is in a growing phase, with the latest annual income totaling USD 37.74M.

Undervalued

The company’s latest PE is -11.11, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 49.86M shares, decreasing 1.79% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 652.18K shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of -0.20.

Financial Health

Currency: USD Updated：2025-09-17

The company's current financial score is 6.75, which is lower than the Healthcare Equipment & Supplies industry's average of 7.32. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 10.29M, representing a year-over-year increase of 7.00%, while its net profit experienced a year-over-year increase of 33.45%.

Score

Industry at a Glance

Previous score

6.75

Change



Financials

6.05

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

7.04

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

6.70

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

6.84

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.09

Key Metrics

Free cash flow

No Data

Company Valuation

Currency: USD Updated：2025-09-17

The company’s current valuation score is 1.20, which is lower than the Healthcare Equipment & Supplies industry's average of 2.00. Its current P/E ratio is -11.11, which is -82.59% below the recent high of -1.93 and 20.17% above the recent low of -8.87.

Score

Industry at a Glance

Previous score

2.00

Change

-0.8

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 66/207

No Data

Earnings Forecast

Currency: USD Updated：2025-09-17

The company’s current earnings forecast score is 8.00, which is higher than the Healthcare Equipment & Supplies industry's average of 7.70. The average price target for Alpha Teknova Inc is 10.00, with a high of 12.00 and a low of 8.00.

Score

Industry at a Glance

Previous score

8.00

Change

Support & Resistance

No Data

Analyst Rating

Based on 6 analysts

Buy

Current Rating

10.000

Target Price

+127.27%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

118

Total

Median

Average

Company name

Ratings

Analysts

Alpha Teknova Inc

TKNO

Medtronic PLC

MDT

Stryker Corp

SYK

Abbott Laboratories

ABT

Zimmer Biomet Holdings Inc

ZBH

Dexcom Inc

DXCM

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated：2025-09-17

The company’s current price momentum score is 7.02, which is higher than the Healthcare Equipment & Supplies industry's average of 6.45. Sideways: Currently, the stock price is trading between the resistance level at 4.91 and the support level at 3.91, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.80

Change

0.22

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(4)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

0.068

Neutral

RSI(14)

48.553

Neutral

STOCH(KDJ)(9,3,3)

68.025

Neutral

ATR(14)

0.294

Low Volatility

CCI(14)

86.447

Neutral

Williams %R

40.645

Buy

TRIX(12,20)

-0.204

Sell

StochRSI(14)

0.000

Sell

Moving Average

Sell(2)

Neutral(0)

Buy(4)

Indicators

Value

Direction

MA5

4.474

Buy

MA10

4.353

Buy

MA20

4.391

Buy

MA50

4.528

Buy

MA100

5.224

Sell

MA200

6.229

Sell

Institutional Confidence

Currency: USD Updated：2025-09-17

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Equipment & Supplies industry's average of 6.89. The latest institutional shareholding proportion is 93.29%, representing a quarter-over-quarter decrease of 1.51%. The largest institutional shareholder is The Vanguard, holding a total of 652.18K shares, representing 1.22% of shares outstanding, with 20.26% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Telegraph Hill Partners

37.72M

Davis (Ted)

1.89M

Davis (Irene)

1.69M

UBS Financial Services, Inc.

1.16M

+4.17%

Balyasny Asset Management LP

836.96K

-16.44%

Mackowski J Matthew

820.81K

Lowell (Matthew)

820.81K

+589.51%

The Vanguard Group, Inc.

Star Investors

573.45K

+6.15%

BlackRock Institutional Trust Company, N.A.

135.79K

-4.12%

Risk Assessment

Currency: USD Updated：2025-09-17

The company’s current risk assessment score is 3.17, which is lower than the Healthcare Equipment & Supplies industry's average of 3.87. The company's beta value is 0.32. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.